Therapix Biosciences Ltd.
5 Azrieli Center (Square Tower)
Tel-Aviv 6702501, Israel
December 20, 2016
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| RE: | Therapix Biosciences Ltd. (CIK: 0001611746) | |
| Registration Statement No. 333-214458 on Form F-1 (the “Registration Statement”) | ||
Ladies and Gentlemen:
Therapix Biosciences Ltd. hereby withdraws its request submitted on December 16, 2016, for acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended.
| Very truly yours, | ||
| Therapix Biosciences Ltd. | ||
| By: | /s/ Dr. Elran Haber | |
| Dr. Elran Haber, Chief Executive Officer | ||
